SUCNR1 and neoplasm: The tumor-derived succinate is taken up through succinate receptor (SUCNR1) and results in the polarization of TAMs into a pro-tumoral form via the SUCNR1/PI3K/HIF1α signaling pathway to enhance tumor metastasis, which can also be mediated by autocrine succinate 34.